{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T02:11:42Z","timestamp":1780625502598,"version":"3.54.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T00:00:00Z","timestamp":1644451200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.eplepsyres.2022.106881","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T17:40:47Z","timestamp":1644255647000},"page":"106881","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Elevation of brain gamma\u2010aminobutyric acid levels is associated with vigabatrin\u2010associated brain abnormalities on magnetic resonance imaging"],"prefix":"10.1016","volume":"181","author":[{"given":"Azusa","family":"Ikeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moyoko","family":"Tomiyasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Tsuyusaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizue","family":"Iai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Aida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohide","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2022.106881_bib1","series-title":"Nelson Textbook of Pediatrics","year":"2003"},{"issue":"Suppl 2","key":"10.1016\/j.eplepsyres.2022.106881_bib2","first-page":"S11","article-title":"Effect of long\u2010term vigabatrin therapy on selected neurotransmitter concentrations in cerebrospinal fluid","volume":"6","author":"Ben-Menachem","year":"1991","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.eplepsyres.2022.106881_bib3","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1111\/epi.16663","article-title":"Fulminant vigabatrin toxicity during combination therapy with adrenocorticotropic hormone for infantile spasms: Three cases and review of the literature","volume":"61","author":"Bhalla","year":"2020","journal-title":"Epilepsia"},{"issue":"2 suppl","key":"10.1016\/j.eplepsyres.2022.106881_bib4","first-page":"S52","article-title":"Therapeutic trial of vigabatrin in refractory infantile spasms","volume":"6","author":"Chiron","year":"1991","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.eplepsyres.2022.106881_bib5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ejpn.2012.10.009","article-title":"Are vigabatrin induced T2 hyperintensities in cranial MRI associated with acute encephalopathy and extrapyramidal symptoms?","volume":"17","author":"Dill","year":"2013","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.eplepsyres.2022.106881_bib6","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/j.1528-1167.2010.02564.x","article-title":"Vigabatrin\u2010associated reversible MRI signal changes in patients with infantile spasms","volume":"51","author":"Dracopoulos","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2022.106881_bib7","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1212\/01.WNL.0000115385.45515.DF","article-title":"Proton MR spectroscopy in succinic semialdehyde dehydrogenase deficiency","volume":"62","author":"Ethofer","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2022.106881_bib8","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/dmcn.12188","article-title":"An investigation into the relationship between vigabatrin, movement disorders, and brain magnetic resonance imaging abnormalities in children with infantile spasms","volume":"55","author":"Fong","year":"2013","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.eplepsyres.2022.106881_bib9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/019262339001800201","article-title":"Chronic toxicity studies with vigabatrin, a GABA\u2010transaminase inhibitor","volume":"18","author":"Gibson","year":"1990","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.eplepsyres.2022.106881_bib10","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/0920-1211(88)90015-0","article-title":"Inhibitory and excitatory amino acids in CSF of patients suffering from complex partial seizures during chronic treatment with gamma\u2010vinyl GABA (vigabatrin)","volume":"2","author":"Halonen","year":"1988","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2022.106881_bib11","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/epi.13712","article-title":"Risk of vigabatrin\u2010associated brain abnormalities on MRI in the treatment of infantile spasms is dose\u2010dependent","volume":"58","author":"Hussain","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2022.106881_bib12","first-page":"7","article-title":"Serial magnetic resonance imaging and 1H\u2010magnetic resonance spectroscopy in GABA transaminase deficiency: A case report","volume":"43","author":"Ichikawa","year":"2018","journal-title":"JIMD Rep."},{"key":"10.1016\/j.eplepsyres.2022.106881_bib13","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1212\/WNL.0000000000003936","article-title":"Phenotype of GABA\u2010transaminase deficiency","volume":"88","author":"Koenig","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2022.106881_bib14","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1111\/j.1528-1167.2010.02772.x","article-title":"Prevalence of visual field loss following exposure to vigabatrin therapy: A systematic review","volume":"51","author":"Maguire","year":"2010","journal-title":"Epilepsia"},{"issue":"Suppl 5","key":"10.1016\/j.eplepsyres.2022.106881_bib15","first-page":"S29","article-title":"Vigabatrin: effects on human brain GABA levels by nuclear magnetic resonance spectroscopy","volume":"35","author":"Mattson","year":"1994","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2022.106881_bib16","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1212\/WNL.0000000000006744","article-title":"Paroxysmal dyskinesias with drowsiness and thalamic lesions in GABA transaminase deficiency","volume":"92","author":"Morales-Brice\u00f1o","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2022.106881_bib17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1468-1331.2003.00506.x","article-title":"Effects of vigabatrin on brain GABA+\/Cr signals in focus\u2010distant and focus\u2010near brain regions monitored by 1H\u2010NMR spectroscopy","volume":"10","author":"Mueller","year":"2003","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.eplepsyres.2022.106881_bib18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1528-1157.2001.077889.x","article-title":"Effects of vigabatrin on brain GABA+\/CR signals in patients with epilepsy monitored by 1H\u2010NMR\u2010spectroscopy: Responder characteristics","volume":"42","author":"Mueller","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2022.106881_bib19","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3233\/PEP-14097","article-title":"Disorders of GABA metabolism: SSADH and GABA\u2010transaminase deficiencies","volume":"3","author":"Parviz","year":"2014","journal-title":"J. Pediatr. Epilepsy"},{"key":"10.1016\/j.eplepsyres.2022.106881_bib20","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10545-009-1034-y","article-title":"Succinic semialdehyde dehydrogenase deficiency: Lessons from mice and men","volume":"32","author":"Pearl","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.eplepsyres.2022.106881_bib21","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1528-1167.2008.01728.x","article-title":"Cerebral MRI abnormalities associated with vigabatrin therapy","volume":"50","author":"Pearl","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2022.106881_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF02740605","article-title":"Measuring human brain GABA in vivo: Effects of GABA\u2010transaminase inhibition with vigabatrin","volume":"16","author":"Petroff","year":"1998","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.eplepsyres.2022.106881_bib23","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1528-1157.1995.tb00486.x","article-title":"Initial observations on effect of vigabatrin on in vivo 1H spectroscopic measurements of gamma\u2010aminobutyric acid, glutamate, and glutamine in human brain","volume":"36","author":"Petroff","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2022.106881_bib24","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1528-1157.1995.tb01672.x","article-title":"Use of ex vivo magnetic resonance imaging to detect onset of vigabatrin\u2010induced intramyelinic edema in canine brain","volume":"36","author":"Peyster","year":"1995","journal-title":"Epilepsia"},{"issue":"Suppl 1","key":"10.1016\/j.eplepsyres.2022.106881_bib25","first-page":"87S","article-title":"Cerebrospinal fluid GABA and seizure control with vigabatrin","volume":"27","author":"Riekkinen","year":"1989","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2022.106881_bib26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10545-009-9022-9","article-title":"A new case of GABA transaminase deficiency facilitated by proton MR spectroscopy","volume":"33","author":"Tsuji","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.eplepsyres.2022.106881_bib27","series-title":"Physician\u2019s Guide to the Diagnosis, Treatment, and Follow\u2010up of Inherited Metabolic Diseases","first-page":"63","article-title":"Disorders of glycine, serine, GABA, and proline metabolism","author":"Van Hove","year":"2014"},{"key":"10.1016\/j.eplepsyres.2022.106881_bib28","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1001\/jamaneurol.2013.1858","article-title":"Reversible vigabatrin\u2010induced life\u2010threatening encephalopathy","volume":"71","author":"Vega","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.eplepsyres.2022.106881_bib29","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s10545-018-0153-8","article-title":"Succinic semialdehyde dehydrogenase deficiency, a disorder of GABA metabolism: An update on pharmacological and enzyme\u2010replacement therapeutic strategies","volume":"41","author":"Vogel","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.eplepsyres.2022.106881_bib30","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1212\/WNL.0000000000001069","article-title":"Vigabatrin retinal toxicity in children with infantile spasms: An observational cohort study","volume":"83","author":"Westall","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2022.106881_bib31","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1528-1167.2008.01896.x","article-title":"Magnetic resonance imaging abnormalities associated with vigabatrin in patients with epilepsy","volume":"50","author":"Wheless","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2022.106881_bib32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1528-1167.2008.01988.x","article-title":"Vigabatrin: 2008 update","volume":"50","author":"Willmore","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2022.106881_bib33","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/epi.13057","article-title":"Summary of recommendations for the management of infantile seizures: Task Force Report for the ILAE Commission of Pediatrics","volume":"56","author":"Wilmshurst","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2022.106881_bib34","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1177\/019262339302100507","article-title":"Sequential neuropathology of dogs treated with vigabatrin, a GABA\u2010transaminase inhibitor","volume":"21","author":"Yarrington","year":"1993","journal-title":"Toxicol. Pathol."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121122000328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121122000328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T02:17:52Z","timestamp":1741918672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121122000328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":34,"alternative-id":["S0920121122000328"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2022.106881","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevation of brain gamma\u2010aminobutyric acid levels is associated with vigabatrin\u2010associated brain abnormalities on magnetic resonance imaging","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2022.106881","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106881"}}